Home
/
Environmental Toxins

DEP: A Shared Urinary Marker of Organophosphate Pesticide Exposure

REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
May 30, 2026
Last updated
June 3, 2026
Key takeaway:

This urine test measures diethyl phosphate (DEP), a breakdown product of organophosphate pesticides, to reveal your recent pesticide exposure so you can take steps to reduce it. Lowering exposure may help reduce risks linked to organophosphates, including nervous system effects and potential impacts on child development and reproductive health.

Read more →
Table of contents

DEP: A shared urinary marker for several organophosphates

Diethyl phosphate (DEP) is a common breakdown product of several organophosphate (OP) insecticides. Instead of measuring each pesticide separately, many labs look for DEP in urine as a “biomarker” of recent OP exposure from sources like produce residues, household or garden insecticides, and certain occupational environments. Exposure can occur through ingestion, inhalation, or skin contact. Most clinical and public health labs quantify DEP in spot urine samples, often with creatinine correction to account for dilution, and results reflect recent exposure over roughly the past day or two, not long-term body burden.

Why it matters: OPs primarily act by inhibiting acetylcholinesterase, the enzyme that helps turn off nerve signaling. While high-level exposures cause acute toxicity, population studies focus on low-level, chronic contact and its potential links to neurologic and developmental outcomes. The body absorbs OPs, rapidly converts them to dialkyl phosphate metabolites like DEP, and excretes them in urine. DEP does not bioaccumulate for months or years like certain heavy metals; it turns over quickly. That speed is useful for spotting recent contact, though it also means single measurements can miss day-to-day variability. Research programs, including national biomonitoring, have found DEP detectable in many people at low levels, underscoring how common incidental exposure is in everyday life.

Why measuring DEP matters

DEP connects directly to how OP insecticides interact with the nervous system. By measuring DEP, you get a read on whether you have had recent exposure that could contribute to nonspecific symptoms such as headaches, lightheadedness, or unusual fatigue in sensitive individuals. It can also help differentiate incidental contact from sustained exposure that may come from routine household use, workplace tasks, or frequent handling of treated materials. Testing is often most informative during pregnancy or fertility planning, in households with young children, and in occupations with potential OP contact, where even small reductions in exposure can matter over time.

What it can do: flag recent contact with one or more diethyl-substituted OPs, help differentiate incidental from recurring exposure, and support decision making during sensitive life stages. What it cannot do: identify the exact pesticide, quantify long-term cumulative risk on its own, or diagnose illness. Because preformed dialkyl phosphates can exist in the environment and on foods, urinary DEP may sometimes reflect environmental degradation products rather than direct exposure to active pesticides. Method differences between labs, timing of collection, and sample dilution all influence results.

Who tends to benefit most from DEP testing

People planning a pregnancy, households with infants and toddlers, workers with potential OP contact, and anyone troubleshooting unexplained symptoms that seem to cluster after specific activities may find DEP testing informative. It can also be useful for those making product or workplace changes who want objective feedback on whether exposure is trending downward.

Reading a DEP result

Labs typically report DEP relative to a population-based reference range. For environmental toxins, lower values are generally preferable when feasible, and a clinician's interpretation improves when you know what happened in the day or two before the test. Because DEP reflects short-term exposure, repeating measurements or pairing them with timing notes can clarify whether a finding is a one-off or part of a steady pattern.

Relatively low values usually indicate minimal recent exposure and a low likelihood of short-term stress on neural signaling or detoxification pathways. In pregnancy and early childhood, where the nervous system is developing rapidly, maintaining low exposure is considered prudent by most public health bodies, though absolute risk at low levels is difficult to quantify and depends on many factors.

Relatively higher values can signal recent or ongoing exposure and may suggest greater workload on metabolic and clearance pathways in the liver and kidneys. Depending on the overall exposure picture, some people notice nonspecific neurologic or cognitive symptoms. Because DEP is a common metabolite across several OPs and because preformed DEP can be present on foods, a single elevated result does not identify the exact pesticide or confirm toxicity. Confirmation with trends, context, and where needed, additional biomarkers is the best approach.

Consider three elements for interpretation: timing, pattern, and co-markers. Timing links the result to recent life — for example, a home pest treatment, a heavy produce-prep day, or a landscaping shift. Pattern looks at repeat testing to see whether DEP returns to baseline or stays elevated. Co-markers include other OP metabolites, general liver and kidney markers, and any symptoms you are tracking. In pregnancy or early childhood, even modest exposures invite a more cautious stance, though individual results require context and more research is ongoing to refine risk thresholds.

How sample timing and daily sources move the number

This is a urine test, often performed on a single spot sample. Many labs correct DEP to urinary creatinine to adjust for hydration, since a very dilute sample can mask exposure while a concentrated sample can exaggerate it. Because DEP has a short half-life, results are most representative of the prior 24–48 hours. If your goal is to understand typical exposure, a repeat sample taken on a different day — ideally with notes about recent activities — adds clarity.

Common exposure pathways include residues on fruits and vegetables, home and garden insecticide use, and occupational contact in agriculture, landscaping, or pest control. Indoor air and dust can carry small amounts when products are applied. OP use in and around homes has declined in many regions due to regulatory changes, yet residues may still be present on imported foods or in certain work settings. People who prepare large volumes of produce, care for pets treated for pests, or spend time in recently treated spaces may see short-term bumps in DEP.

State-of-the-art mass spectrometry methods quantify DEP at very low concentrations. Results may be reported as a raw value and as creatinine-normalized. Both are useful: the raw value shows what was present in that sample, while the normalized value helps compare across days with different hydration. Because population ranges are descriptive rather than health-based, being within a reference range does not prove zero risk — and being above it does not automatically indicate harm. The signal becomes most meaningful when it is interpreted with your broader health picture and, when needed, clinician input.

Big picture: your DEP result is most meaningful in context. Patterns across multiple organophosphate metabolites, alongside general health markers, symptoms, and your recent environment, paint a better picture than a single number. Trends help separate a transient spike after a weekend project from a recurring pattern tied to food handling or work routines. Think of it like tracking workout recovery or sleep scores over weeks — one data point is interesting, but the pattern is what drives smart decisions with your clinician.

Ultimately, your DEP result should be considered alongside related environmental toxin measures, basic health labs, and lived context. Over time, this integrated view distinguishes transient spikes from persistent exposure patterns and supports safer, more targeted choices with a clinician’s guidance.

What a DEP test can and can't tell you

The diethyl phosphate (DEP) environmental toxin test offers a clear snapshot of recent organophosphate exposure, grounded in established biomonitoring science. Use it to spot patterns, connect results to real life, and support safer choices over time. The strongest insights come from trends and context, not a single number, and from aligning results with your goals during key life stages.

FAQs

The DEP test measures the concentration of diethyl phosphate (DEP), a non-specific metabolite and biomarker of exposure to diethyl-substituted organophosphate pesticides. Detected primarily in urine, DEP reflects recent exposure to these pesticides but does not identify the specific parent compound. It is used in biomonitoring to estimate exposure levels, though it does not directly measure toxic effects such as cholinesterase inhibition.

Short answer: consider testing if you suspect exposure or have related health concerns. Diethyl phosphate (DEP) is a common urinary metabolite that most often reflects exposure to diethyl organophosphate pesticides (from agricultural use, pesticide drift, or dietary residues) and to environmental degradates of those chemicals; it is not the same as diethyl phthalate (a plasticizer). Elevated DEP alone doesn't prove harm, but organophosphate exposures have been associated in studies with effects on the nervous system, neurodevelopment, and endocrine functions (including possible impacts on fertility and thyroid), so measuring DEP helps clarify the magnitude and timing of exposure and guides practical reduction strategies (dietary changes, workplace protections, cleaning or remediation, or clinical follow-up when indicated).

Who benefits most: agricultural workers and pesticide applicators; residents or families living near treated fields; people with high-dietary or household pesticide exposure; anyone with unexplained neurological or chronic symptoms after possible exposure; pregnant people or couples planning pregnancy and those with fertility or thyroid concerns; and clinicians or individuals focused on optimizing detox capacity or longevity who want objective exposure data to prioritize interventions.

Establish a baseline by testing once to assess your DEP exposure; if levels are elevated, plan periodic follow-up testing until levels decline (for example, every few months or as recommended by a clinician), and retest whenever you make changes that could affect exposure—such as after changing household products, moving or renovating your home, starting a new job with potential pesticide exposure, or following detoxification efforts.

Several factors can affect diethyl phosphate (DEP) test results: timing of sample collection (levels change over time after exposure); recent exposures from food, air, water, or consumer products; individual metabolism and genetic differences; hydration status, which can dilute or concentrate urinary measurements; and the type of sample collected (urine vs. blood). Certain medications or supplements may also influence readings.

Fasting is not generally required for diethyl phosphate (DEP) testing. A first‑morning urine sample is often preferred because it reduces within‑day variability and concentrates metabolites, but follow the specific instructions from the testing laboratory or study protocol.

It is advisable to avoid new exposures to pesticides or products that may contain organophosphate ingredients if feasible and to record any recent contact with potential sources of DEP (for example: recent pesticide application or nearby spraying, insect repellents, treated surfaces, plastics or packaging, and personal care products like lotions or cosmetics). Note the timing and type of any such product use or environmental contact when you submit the sample so results can be interpreted in context.

Diethyl phosphate (DEP) testing is a useful and generally reliable biomarker for detecting recent exposure to certain organophosphate pesticides, but it is nonspecific — it indicates exposure to compounds that metabolize to DEP rather than identifying the exact parent pesticide. Because DEP and similar dialkyl phosphate metabolites are cleared from the body relatively quickly, urinary DEP levels typically reflect recent exposure (hours to days) rather than cumulative body burden or long‑term exposure history.

References

  1. Costa, L. G. (2006). Current issues in organophosphate toxicology. Clinica Chimica Acta, 366(1-2), 1-13. https://doi.org/10.1016/j.cca.2005.10.008
  2. Barr, D. B., Wong, L. Y., Bravo, R., Weerasekera, G., Odetokun, M., Restrepo, P., Kim, D. G., Fernandez, C., Whitehead, R. D., Perez, J., Gallegos, M., Williams, B. L., & Needham, L. L. (2011). Urinary concentrations of dialkylphosphate metabolites of organophosphorus pesticides: National Health and Nutrition Examination Survey 1999-2004. International Journal of Environmental Research and Public Health, 8(8), 3063-3098. https://doi.org/10.3390/ijerph8083063
  3. Chen, L., Zhao, T., Pan, C., Ross, J. H., & Krieger, R. I. (2012). Preformed biomarkers including dialkylphosphates (DAPs) in produce may confound biomonitoring in pesticide exposure and risk assessment. Journal of Agricultural and Food Chemistry, 60(36), 9342-9351. https://doi.org/10.1021/jf303116p
  4. Bouchard, M. F., Chevrier, J., Harley, K. G., Kogut, K., Vedar, M., Calderon, N., Trujillo, C., Johnson, C., Bradman, A., Barr, D. B., & Eskenazi, B. (2011). Prenatal exposure to organophosphate pesticides and IQ in 7-year-old children. Environmental Health Perspectives, 119(8), 1189-1195. https://doi.org/10.1289/ehp.1003185
  5. Barr, D. B., Wilder, L. C., Caudill, S. P., Gonzalez, A. J., Needham, L. L., & Pirkle, J. L. (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. Environmental Health Perspectives, 113(2), 192-200. https://doi.org/10.1289/ehp.7337

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey